Overview

Adiposity and Endothelin Receptor Function

Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
Elevated levels of ET-1 have been implicated in cardiovascular disease and some forms of hypertension. Due to the strong, positive correlation between obesity and hypertension, the present study will explore the contribution of adiposity in ETB receptor function and aim to elucidate if ETB receptor dysfunction is a major contributor to hypertension in obesity.
Phase:
Early Phase 1
Details
Lead Sponsor:
Augusta University
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Candesartan
Candesartan cilexetil